<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45">
 <label>45.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Furuta</surname>
    <given-names>Y</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gowen</surname>
    <given-names>BB</given-names>
   </name>, 
   <name name-style="western">
    <surname>Takahashi</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shiraki</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Smee</surname>
    <given-names>DF</given-names>
   </name>, 
   <name name-style="western">
    <surname>Barnard</surname>
    <given-names>DL</given-names>
   </name>
  </person-group>
  <year>2013</year>
  <article-title>Favipiravir (T-705), a novel viral RNA polymerase inhibitor</article-title>. 
  <source>Antiviral Res</source>
  <volume>100</volume>:
  <fpage>446</fpage>â€“
  <lpage>454</lpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2013.09.015</pub-id>.
  <pub-id pub-id-type="pmid">24084488</pub-id>
 </mixed-citation>
</ref>
